Has Maryah Mansoor, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,405 in general payments to Maryah Mansoor, MD across 19 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Maryah Mansoor, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Maryah Mansoor, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Maryah Mansoor, MD

Rheumatology · Peoria, ILNPI 1659684777

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,670 of the $8,405 with a category attached, or 79.4%. Boehringer Ingelheim accounts for 71.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $6,307 and has fallen 98.9% since, to $70 in 2023.

$8,405in general payments, 2019–2025

Across 19 payments — averaging $442.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boehringer Ingelheim$6K
Pfizer$2K
GSK$162
Novartis$112
Cardinal Health 110 LLC$100
Johnson & Johnson$55
plus $35 from 1 others

What the payments were for

Consulting fees$6,67079%
Travel & lodging$1,08813%
Food & beverage$5717%
Education$751%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boehringer Ingelheim	10	$6,033
Pfizer	2	$1,907
GSK	2	$162
Novartis	1	$112
Cardinal Health 110 LLC	1	$100
Johnson & Johnson	1	$55
Amgen	2	$35

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

OFEV$5,718
XELJANZ$1,900
COSENTYX$112

How this compares

$8,405 in reported general payments places this provider in the 75th percentile of 287 rheumatology providers in Illinois.

See all rheumatology providers in Illinois →

Medicare billing

Part B allowed, 2024

$202,574

Medicare patients

Services billed

11,447

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydroxychloroquine Sulfate	34	$1,921
MethotrexateMethotrexate Sodium	32	$1,232
Prednisone	30	$239

Paid to pharmacies, not to this prescriber.

Other rheumatology in Peoria

Vaughn HannaPeoria$42K
Manish JainChicago$1.9M
Lori SiegelBannockburn$1.5M
Alfonso BelloGlenview$611K
Theodore PincusChicago$524K
Angela CrowleyWillowbrook$483K
Eric RudermanChicago$440K
Anisha DuaChicago$280K
Arthur MandelinChicago$270K
Jeffrey HorvathSpringfield$246K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →